Rabih R. Azar

ORCID: 0000-0001-7748-446X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Lipoproteins and Cardiovascular Health
  • Coronary Interventions and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cardiac Arrhythmias and Treatments
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac Valve Diseases and Treatments
  • Blood Pressure and Hypertension Studies
  • Heart Failure Treatment and Management
  • Cardiac electrophysiology and arrhythmias
  • Atherosclerosis and Cardiovascular Diseases
  • Heart Rate Variability and Autonomic Control
  • Advanced MRI Techniques and Applications
  • Mechanical Circulatory Support Devices
  • Advanced X-ray and CT Imaging
  • Cardiac tumors and thrombi
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Disease and Adiposity
  • Cardiac pacing and defibrillation studies
  • Vitamin K Research Studies
  • Macrophage Migration Inhibitory Factor
  • Acute Ischemic Stroke Management

Hôtel-Dieu de Paris
2005-2024

Saint Joseph University
2011-2022

Hôtel-Dieu de France
2011-2022

Bridge University
2022

In-Q-Tel
2019

Centre Hospitalier de Vitré
2012-2016

Cardiovascular Institute of the South
2015

Saint Joseph's University
2006

Hartford Hospital
1995-2003

San Francisco General Hospital
2000-2002

Menno V. Huisman Kenneth J. Rothman Miney Paquette Christine Teutsch Hans‐Christoph Diener and 95 more Sérgio Dubner Jonathan L. Halperin Chang Sheng Kristina Zint Amelie Elsaesser Dorothee B. Bartels Gregory Y.H. Lip Dzifa Wosornu Abban Nasser Abdul Mark Abelson Alan Ackermann Fran Adams Luthando Adams Pedro Adragão Walter Ageno Rajesh Aggarwal Sergio Agosti Javier A. Marin Francisco Aguilar Julio Alberto Aguilar Linares Luis Aguinaga Zia Ahmad Paul Ainsworth Kamal Al Ghalayini Saad Al Ismail Abdelfatah Alasfar Abdul Alawwa Raed Al-Dallow Lisa Alderson Dimitrios Alexopoulos Abdullah Ali Malik Ali Pareed Aliyar Tammam Al-Joundi Soufian Al Mahameed Hossein Almassi Khalid Almuti Mohamed Al-Obaidi Mohamed Al‐Shehri Ute Altmann Alvaro Rabelo Alves Ayham Al-Zoebi W. Amara Mathieu Amelot Nima Amjadi Fabrizio Ammirati Nabil Andrawis Denis Angoulvant Giorgio Annoni Gerardo Ansalone Sorin Alexandru Antonescu M. Kevin Ariani Juan Carlos Arias Sébastien Armero Rohit Arora Chander Arora William Ashcraft Muhammad Shakil Aslam Alfredo Astesiano Philippe Audouin Charles Augenbraun Şenay Aydın Rabih R. Azar Abul Azim Shahid Aziz Luciano Marcelo Backes Mirza Amir Baig Suchdeep Bains Asaad I. Bakbak Seth Baker Karim Bakhtiar Richard Bala Jonathan Banayan Stellan Bandh Shigenobu Bando Subhash Banerjee Alan J. Bank О. Л. Барбараш Gonzalo Barón‐Esquivias Craig Barr Carlos M. Barrera John R. Barton Vanja Bašić Kes Giovanni Baula Hamid el Bayeh Nooshin Bazargani Steffen Behrens Alan Bell Juan Benezet‐Mazuecos Bouziane Benhalima Philippe Berdagué Brian J. Berg van den P.F.M.M. Bergen van Edvard Berngard Richard A. Bernstein

GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns patients newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non–vitamin K antagonist oral anticoagulant (NOAC), became available. This study sought to describe phase baseline data and compare these pre-NOAC era collected during 1. During 2,...

10.1016/j.jacc.2016.11.061 article EN cc-by-nc-nd Journal of the American College of Cardiology 2017-02-01

The prevalence and factors related to hypertension (HTN) treatment control are well investigated in the Western world but remain poorly understood Middle East middle‐income countries such as Lebanon. In order measure prevalence, awareness, treatment, rates of HTN Lebanon, authors measured blood pressure (BP) 1697 adults. optimal BP (<120/80 mm Hg) was 33% that pre‐HTN (BP ≥120/80 Hg <140/90 30%. (among treated hypertensive) were 36.9%, 53%, 48.9%, 54.2%, respectively. Overall, only 27%...

10.1111/jch.12485 article EN Journal of Clinical Hypertension 2015-01-24

Waterpipe smoking is becoming a popular way of tobacco use in the world. Its acute effects on cardiovascular system are not well investigated.This trial designed to evaluate waterpipe blood pressure (BP) and heart rate (HR) healthy adults. Individuals who ordered 6 Lebanese restaurants were enrolled (cases) compared controls consisted subjects sitting at same table smokers but did smoke (passive smokers) nonsmoking sections (nonsmokers). BP HR measured immediately before 15 min after or...

10.3109/08958378.2016.1171934 article EN Inhalation Toxicology 2016-04-25

Aims The purpose of this study was to assess the efficacy antiinflammatory therapy with methylprednisolone during acute phase unstable angina.

10.1053/euhj.2000.2475 article EN European Heart Journal 2000-12-15
Coming Soon ...